Rotavirus in the Northern Territory before and after vaccination

Thomas Snelling, Peter Markey, Jonathan Carapetis, Ross Andrews

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Globally, rotavirus vaccines have been found to have reduced effectiveness in resource-poor and high disease burden settings. Prior to vaccination, the burden of rotavirus gastroenteritis was substantially higher among
Indigenous children in the Northern Territory (NT) than among other Australian children, giving rise to concern about the likely impact of vaccination in this population. Post-licensure studies in the NT indicate that vaccination
protects infants against hospitalisation in this setting, but vaccine effectiveness (VE) among older children and against heterotypic serotypes needs to be more clearly determined.
Original languageEnglish
Pages (from-to)61-63
Number of pages3
JournalMicrobiology Australia
Volume33
Issue number2
Publication statusPublished - 2012

Fingerprint

Northern Territory
Rotavirus
Vaccination
Rotavirus Vaccines
Gastroenteritis
Licensure
Hospitalization
Vaccines
Population

Cite this

Snelling, Thomas ; Markey, Peter ; Carapetis, Jonathan ; Andrews, Ross. / Rotavirus in the Northern Territory before and after vaccination. In: Microbiology Australia. 2012 ; Vol. 33, No. 2. pp. 61-63.
@article{7bc956c2744a4b218df08527bc8a7da6,
title = "Rotavirus in the Northern Territory before and after vaccination",
abstract = "Globally, rotavirus vaccines have been found to have reduced effectiveness in resource-poor and high disease burden settings. Prior to vaccination, the burden of rotavirus gastroenteritis was substantially higher amongIndigenous children in the Northern Territory (NT) than among other Australian children, giving rise to concern about the likely impact of vaccination in this population. Post-licensure studies in the NT indicate that vaccinationprotects infants against hospitalisation in this setting, but vaccine effectiveness (VE) among older children and against heterotypic serotypes needs to be more clearly determined.",
author = "Thomas Snelling and Peter Markey and Jonathan Carapetis and Ross Andrews",
year = "2012",
language = "English",
volume = "33",
pages = "61--63",
journal = "Microbiology Australia",
issn = "1324-4272",
publisher = "The Australian Society for Microbiology",
number = "2",

}

Snelling, T, Markey, P, Carapetis, J & Andrews, R 2012, 'Rotavirus in the Northern Territory before and after vaccination', Microbiology Australia, vol. 33, no. 2, pp. 61-63.

Rotavirus in the Northern Territory before and after vaccination. / Snelling, Thomas; Markey, Peter; Carapetis, Jonathan; Andrews, Ross.

In: Microbiology Australia, Vol. 33, No. 2, 2012, p. 61-63.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Rotavirus in the Northern Territory before and after vaccination

AU - Snelling, Thomas

AU - Markey, Peter

AU - Carapetis, Jonathan

AU - Andrews, Ross

PY - 2012

Y1 - 2012

N2 - Globally, rotavirus vaccines have been found to have reduced effectiveness in resource-poor and high disease burden settings. Prior to vaccination, the burden of rotavirus gastroenteritis was substantially higher amongIndigenous children in the Northern Territory (NT) than among other Australian children, giving rise to concern about the likely impact of vaccination in this population. Post-licensure studies in the NT indicate that vaccinationprotects infants against hospitalisation in this setting, but vaccine effectiveness (VE) among older children and against heterotypic serotypes needs to be more clearly determined.

AB - Globally, rotavirus vaccines have been found to have reduced effectiveness in resource-poor and high disease burden settings. Prior to vaccination, the burden of rotavirus gastroenteritis was substantially higher amongIndigenous children in the Northern Territory (NT) than among other Australian children, giving rise to concern about the likely impact of vaccination in this population. Post-licensure studies in the NT indicate that vaccinationprotects infants against hospitalisation in this setting, but vaccine effectiveness (VE) among older children and against heterotypic serotypes needs to be more clearly determined.

UR - http://microbiology.publish.csiro.au/nid/206/issue/6816.htm

M3 - Article

VL - 33

SP - 61

EP - 63

JO - Microbiology Australia

JF - Microbiology Australia

SN - 1324-4272

IS - 2

ER -